Authors: Arbyn, M Van Oyen, H Lynge, E Mickshe, M

Citation: M. Arbyn et al., European consensus on cancer screening should be applied urgently by health ministers, BR MED J, 323(7309), 2001, pp. 396-396

Authors: van Ballegooijen, M van den Akker-van Marle, E Patnick, J Lynge, E Arbyn, M Anttila, A Ronco, G Dik, J Habbema, F

Citation: M. Van Ballegooijen et al., Overview of important cervical cancer screening process values in EuropeanUnion (EU) countries, and tentative predictions of the corresponding effectiveness and cost-effectiveness, EUR J CANC, 36(17), 2000, pp. 2177-2188

Authors: Arbyn, M Van Oyen, H

Citation: M. Arbyn et H. Van Oyen, Cervical cancer screening in Belgium, EUR J CANC, 36(17), 2000, pp. 2191-2197

Authors: Arbyn, M Schenck, U

Citation: M. Arbyn et U. Schenck, Detection of false negative pap smears by rapid reviewing - A metaanalysis, ACT CYTOL, 44(6), 2000, pp. 949-957

Authors: Mody, DR Davey, DD Branca, M Raab, SS Schenck, UG Stanley, MW Wright, RG Arbyn, M Beccati, D Bishop, JW Collaco, LM Cramer, SF Fitzgerald, P Heinrich, J Jhala, NC Montanari, G Kapila, K Naryshkin, S Suprun, HZ

Citation: Dr. Mody et al., Quality assurance and risk reduction guidelines, ACT CYTOL, 44(4), 2000, pp. 496-507

Authors: Arbyn, M Wallyn, S Van Oyen, H

Citation: M. Arbyn et al., The new law on privacy protection: Perspectives for organised cancer screening, ACT CLIN B, 54(3), 1999, pp. 147-149